Tag: Cancer: Lung
Complications Higher Than Expected for Invasive Lung Tests
Complication rates for invasive lung diagnostic procedures higher than those seen in clinical trials
Median Survival for Stage 4 ALK-Positive NSCLC Nearly 7 Years
Most patients in study received crizotinib; prognosis worse when more organs have tumors at diagnosis
Childhood Hodgkin Lymphoma Survivors at Risk for Later Cancers
Survivors have 14-fold increased risk for developing a solid subsequent malignant neoplasm
Elevated Risk for Lung CA in Lung Transplant Recipients Explored
13-fold increased risk found in native lung for those receiving single lung transplant
Lung Cancer Screening Implementation Guide Developed
Implementation guide designed to increase levels of lung cancer screening for heavy smokers
Immunotherapy Side Effects May Be More Common Than Thought
Higher rates of adverse events observed for immune checkpoint inhibitors in real-world settings
More Frequent Surveillance No Benefit After NSCLC Resection
More frequent postsurgical surveillance is not associated with improved survival
Models Project 79 Percent Drop in Lung CA Mortality by 2065
Annual number of deaths expected to continue to decrease despite growth, aging of U.S. population
Angiotensin-Converting Enzyme Inhibitors May Up Lung CA Risk
Higher risk seen with ACEIs versus angiotensin receptor blockers; risk linked to duration of use
Durvalumab Extends Survival in Stage III Non-Small Cell Lung CA
Both overall and progression-free survival longer with durvalumab than with placebo
